Vidi, V. D., Matheny, M. E., Agarwal, V., Arora, N., Donnelly, S., Bangalore, S., & Resnic, F. S. (2010). Validation of Long-term Benefits of Bivalirudin vs. Unfractionated Heparin in Routine Clinical Practice after Percutaneous Coronary Intervention.

Vidi, Venkatesan D., Michael E. Matheny, Vikram Agarwal, Nipun Arora, Sharon Donnelly, Sripal Bangalore, and Frederic S. Resnic. Validation of Long-term Benefits of Bivalirudin Vs. Unfractionated Heparin in Routine Clinical Practice After Percutaneous Coronary Intervention. 2010.

Vidi, Venkatesan D., et al. Validation of Long-term Benefits of Bivalirudin Vs. Unfractionated Heparin in Routine Clinical Practice After Percutaneous Coronary Intervention. 2010.